Simple mathematical data processing method for the determination of sever overlapped spectra of linagliptin and empagliflozin in their pure forms and pharmaceutical formulation: Fourier self deconvulated method
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Simple mathematical data processing method for the determination of sever overlapped spectra of linagliptin and empagliflozin in their pure forms and pharmaceutical formulation: Fourier self deconvulated method
Authors
Keywords
Spectrophotometry, Fourier self deconvulation, Empagliflozin, Linagliptin
Journal
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
Volume 254, Issue -, Pages 119609
Publisher
Elsevier BV
Online
2021-02-23
DOI
10.1016/j.saa.2021.119609
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Validated Voltammetric Method for the Simultaneous Determination of Anti‐diabetic Drugs, Linagliptin and Empagliflozin in Bulk, Pharmaceutical Dosage Forms andBiological Fluids
- (2020) Mohamed Rizk et al. ELECTROANALYSIS
- Quantitative determination of potential genotoxic impurity 3‐aminopyridine in linagliptin active pharmaceutical ingredient using HILIC–UV
- (2020) Bashar Al‐Sabti et al. BIOMEDICAL CHROMATOGRAPHY
- Application of online liquid chromatography/quadrupole time‐of‐flight electrospray ionization tandem mass spectrometry for structural characterization of Linagliptin degradation products and related impurities
- (2020) Amrej Singh Yadav et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- New spectrofluorimetric analysis of empagliflozin in its tablets and human plasma using two level full factorial design
- (2020) Mahmoud A. Omar et al. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
- Square-wave Adsorptive Anodic Stripping Voltammetric Determination of Antidiabetic Drug Linagliptin in Pharmaceutical Formulations and Biological Fluids Using a Pencil Graphite Electrode
- (2020) Ahmed. H. NAGGAR et al. ANALYTICAL SCIENCES
- Stability Indicating, pH and pKa Dependent HPLC–DAD Method for the Simultaneous Determination of Weakly Ionizable Empagliflozin, Dapagliflozin and Canagliflozin in Pharmaceutical Formulations
- (2020) Shahzad Sharif et al. CHROMATOGRAPHIA
- A capillary electrophoresis method for the determination of the linagliptin enantiomeric impurity
- (2020) Xuan‐Lan Mai et al. JOURNAL OF SEPARATION SCIENCE
- Determination of empagliflozin in the presence of its organic impurities and identification of two degradation products using UHPLC-QTOF/MS
- (2020) Joanna Wittckind Manoel et al. MICROCHEMICAL JOURNAL
- Biological Safety Studies and Simultaneous Determination of Linagliptin and Synthetic Impurities by LC-PDA
- (2019) Raquel Balestri Heleno Ferreira et al. Journal of Analytical Methods in Chemistry
- Development of simultaneous determination of empagliflozin and metformin in human plasma using liquid chromatography–mass spectrometry and application to pharmacokinetics
- (2019) Tejas Wattamwar et al. EUROPEAN JOURNAL OF MASS SPECTROMETRY
- Simultaneous Estimation of Empagliflozin and Metformin by High-Performance Thin-Layer Chromatography Using Quality-by-Design Approach
- (2019) Niyatee Saurabh Thakor et al. JPC-JOURNAL OF PLANAR CHROMATOGRAPHY-MODERN TLC
- Liquid chromatographic and spectrofluorimetric assays of empagliflozin: Applied to degradation kinetic study and content uniformity testing
- (2018) Maha F. Abdel-Ghany et al. LUMINESCENCE
- Comparative Study Between Multivariate and Univariate Analysis of Two Antidiabetic Combinations
- (2017) Maha F. Abdel-Ghany et al. JOURNAL OF AOAC INTERNATIONAL
- LC–MS/MS Determination of Empagliflozin and Metformin
- (2017) Bassam M. Ayoub et al. JOURNAL OF CHROMATOGRAPHIC SCIENCE
- Empagliflozin/Linagliptin: Combination therapy in patients with type 2 diabetes
- (2016) Xueying Tan et al. ANNALES D ENDOCRINOLOGIE
- Development and validation of simple spectrophotometric and chemometric methods for simultaneous determination of empagliflozin and metformin: Applied to recently approved pharmaceutical formulation
- (2016) Bassam M. Ayoub SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
- Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes
- (2015) Andrew Lewin et al. DIABETES CARE
- The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review
- (2014) Janet B. McGill Diabetes Therapy
- Validity of Meta-analysis in Diabetes: We Need to Be Aware of Its Limitations
- (2013) P. D. Home DIABETES CARE
- Linagliptin: farmacology, efficacy and safety in type 2 diabetes treatment
- (2013) Erika Paniago Guedes et al. Diabetology & Metabolic Syndrome
- Linagliptin: a novel dipeptidyl peptidase 4 inhibitor with a unique place in therapy
- (2011) Anthony H. Barnett ADVANCES IN THERAPY
- Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors
- (2011) R. Grempler et al. DIABETES OBESITY & METABOLISM
- Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes
- (2009) Carolyn F Deacon et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started